SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001246360-13-000516
Filing Date
2013-01-18
Accepted
2013-01-18 17:00:12
Documents
1
Period of Report
2013-01-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form.html 4  
1 PRIMARY DOCUMENT form.xml 4 12583
  Complete submission text file 0001246360-13-000516.txt   14044
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Quinn Anthony (Reporting) CIK: 0001532219 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 13538156